Status:
COMPLETED
Symbicort in Chronic Obstructive Pulmonary Disease
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
Brief Summary
Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose...
Eligibility Criteria
Inclusion
- Patients with COPD treated with budesonide/formoterol
Exclusion
- limitations; possible risks; warnings; contraindications mentioned in the SPC.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
64730 Patients enrolled
Trial Details
Trial ID
NCT00611520
Start Date
September 1 2005
Last Update
January 28 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.